En Es
Categorías

DxGen Corp.

DxGenco is Point-Of-Care (POC) IVD company focused on developing multi-markers for people with diabetes and tuberculosis. It provides total solutions for POC diagnostics and offers full service for developing POC products from concept through commercialization.
Miembro Oro
Productos Covid-19Resumen
Close

Covid-19 DxGen Corp.

Laboratorio clínico

COVID-19 IgM/IgG Test
Epithod 616 COVID-19 IgM/IgG Test Kit

The Epithod 616 COVID-19 IgM/IgG Test Kit is intended for the semi-quantitative detection of IgM and IgG antibodies to SARS-CoV-2 in whole blood, serum, and plasma from humans with a fast test time of less than two minutes. The gold nanoparticle-based immunoassay test kit is designed for use on the Epithod 616 analyzer which ensures better accuracy and improved sensitivity in analyzing results, and eliminates the risk of undesirable misreading.
Mas detalles
Close

Sobre DxGen Corp.

DxGenco is Point-Of-Care (POC) IVD company focused on developing multi-markers for people with diabetes and tuberculosis. It provides total solutions for POC diagnostics and offers full service for developing POC products from concept through commercialization.
Facebook Twitter Google+ Linked in
COVID-19 IgM/IgG Test

COVID-19 IgM/IgG Test

Modelo: Epithod 616 COVID-19 IgM/IgG Test Kit
Solicite información

Descripción:

The Epithod 616 COVID-19 IgM/IgG Test Kit is intended for the semi-quantitative detection of IgM and IgG antibodies to SARS-CoV-2 in whole blood, serum, and plasma from humans with a fast test time of less than two minutes. The gold nanoparticle-based immunoassay test kit is designed for use on the Epithod 616 analyzer which ensures better accuracy and improved sensitivity in analyzing results, and eliminates the risk of undesirable misreading.


Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
DxGen Corp. ()
* Mensaje

Derecho de autor © 2000-2020 TradeMed.com. Todos los derechos reservados. | Términos y condiciones